Interestingly, in our current study, we found that there was no difference in circulating levels of E2, progesterone, testosterone, FSH and LH between patients with type 1 and type 2 endometrial cancer in either premenopausal or postmenopausal women. The gene discussed is PLOD1; the disease is endometrial cancer.